MedTrace Logo

COVID-19 Infection in Cancer Pantients

NCT04569292 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-09-29

No results posted yet for this study

Summary

It's an obsevational retrospective/prospective study. Analyzing the evolution of COVID 19 infection in cancer patients can provide interesting information in the management of these patients. For this reason, the purpose of this study is to implement a registry to describe and monitor cancer patients affected by COVID 19, the factors that are associated with an unfavorable evolution, to develop a strategy for the risk assessment of these patients and recommendations. relating to their treatment.

Particular attention will be paid to patients suffering from urological tumors because the treatment followed by the patients would seem to expose them to a greater risk when they are infected with coronavirus, furthermore, from the literature it is clear that there may be a connection between sex hormones and ACE2 levels in the plasma. In fact, the estrons up-regulate the concentration of ACE2 in the circulation and this could be the reason why women would seem more protected than men once they contract the coronavirus infection

Conditions

  • Covid19

Interventions

OTHER

No intervention on patients

No intervention on patients

Sponsors & Collaborators

  • Ospedale Andrea Tortora di Pagani

    lead NETWORK

Principal Investigators

  • Giuseppe Di Lorenzo · Oncology Unit

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-04-30
Completion
2021-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04569292 on ClinicalTrials.gov